Every parliamentary written question tabled by Graham Stuart this session, with the full answer and department. Back to the MP page.
Showing 1–5 of 5 · Department of Health and Social Care
What steps he will take where NHS trusts tell patients with Functional Neurological Disorder that their services are not set up to treat the condition, in the context of NHS England's August 2025 Specialised Neurology Service Specification requiring FND to be provided as a core activity at every specialised neurology centre.
Awaiting answer.
What guidance exists on which clinician - GP or neurologist - is responsible for reviewing and managing medication for patients with Functional Neurological Disorder and non-epileptic seizures.
Awaiting answer.
Whether psychological therapy services are fully commissioned across all areas of England to accept referrals for patients with Functional Neurological Disorder and non-epileptic seizures; and what steps he is taking to help tackle gaps where patients are being turned away.
Awaiting answer.
What support his Department plans to offer hospital trusts that are in Strand 4 of the NHS acute trust league table.
The NHS Oversight Framework 2025/26 sets out how NHS England will support trusts to improve, based on an assessment of their performance. This is available at the following link:https://www.england.nhs.uk/long-read/nhs-oversight-framework-2025-26/NHS England works through regional teams to monitor National Health Service trust performance, identify issues, and deliver improvement in the most challenged areas. Improvement metrics and trajectories are agreed and proactively monitored.NHS England may also apply interventions and require NHS trusts to take broad actions or address specific concerns related to known issues. This may involve use of NHS England’s enforcement powers, particularly to secure improvement or where improvement is deemed insufficient.Trusts rated low for both performance and capability will receive support from the National Provider Improvement Programme (NPIP), which will replace the Recovery Support Programme. NPIP will determine whether the most challenged have the necessary conditions in place to deliver sustainable improvement and will ensure support is in place as needed. This will be in addition to any targeted improvement support for specific issues such as urgent and emergency care, outpatients, mental health, finance, or maternity.Additionally, newly appointed very senior managers (VSMs) to NHS trusts in segment 5 will be eligible for ‘challenged organisation recruitment premiums’, to attract talented VSMs to join challenged organisations and help turn them around.
Who the designated board-level executive leads are for Down Syndrome in each ICB in England.
It is the responsibility of integrated care boards (ICBs) to make information public about executive leads for Down syndrome in England. In accordance with statutory guidance published by NHS England on 9 May 2023, ICBs should be open and transparent about who holds these roles and should make this information publicly available. We are giving systems greater control and flexibility, and it is for individual ICBs to decide how to publicise these details.The statutory guidance sets out NHS England’s expectations about fulfilling executive lead functions and outlines the responsibilities of these roles in more detail, and is available at the following link:https://www.england.nhs.uk/publication/executive-lead-roles-within-integrated-care-boards/